Journal of Genetic Counseling

, Volume 22, Issue 3, pp 315–322

Ethical Issues in Presymptomatic Genetic Testing for Minors: A dilemma in Li-Fraumeni Syndrome

  • Brice Fresneau
  • Laurence Brugières
  • Olivier Caron
  • Grégoire Moutel
Original Research


In 2001, a French expert panel recommended that presymptomatic tests should not be carried out on minors in families affected by Li-Fraumeni syndrome (LFS), flying in the face of possible parental demands for such testing. We decided to investigate the legitimacy of such a recommendation. We conducted a national multicenter survey using self-administered questionnaires mailed to French oncogeneticists in 33 regional centers in France. We aimed to (1) determine the extent to which these doctors were confronted with parental requests for TP53 testing, (2) study how they responded to these requests and the arguments used and (3) assess the attitude of oncogeneticists concerning the normative framework regulating the prescription of tests for minors. Twenty oncogeneticists stated that they had managed at least one LFS family. Eleven of these doctors had been confronted with parental requests for testing and three had prescribed such tests on at least one occasion. The oncogeneticists gave balanced medical, psychological and ethical arguments, highlighting the dilemma they face in the decision-making process. This dilemma is due to the lack of a consensus concerning this recommendation, which aims to protect the minor by limiting presymptomatic tests to cases in which a clear medical benefit can be demonstrated but which prevents the unique situation of particular families from being taken into account. In conclusion, the recommendation has a normative status but first, from a clinical stance, it is difficult to dissociate it from the evaluation of individual family situations, and second, the benefit of a specific medical follow-up for TP53 mutation carriers is currently being investigated.


Li-Fraumeni Syndrome Predictive genetic testing Medical ethics Minors 


  1. American-Society-of-Human-Genetics. (1995). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. American Journal of Human Genetics, 57(5), 1233–1241.Google Scholar
  2. Ariffin, H., Martel-Planche, G., Daud, S. S., Ibrahim, K., & Hainaut, P. (2008). Li-Fraumeni syndrome in a Malaysian kindred. Cancer Genetics and Cytogenetics, 186(1), 49–53.PubMedCrossRefGoogle Scholar
  3. Beauchamp, T., & Childress, J. (2008). Principles of biomedical ethics, 6th edition.Google Scholar
  4. Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70(5), 374–381.PubMedCrossRefGoogle Scholar
  5. Borry, P., Evers-Kiebooms, G., Cornel, M. C., Clarke, A., & Dierickx, K. (2009). Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. European Journal of Human Genetics, 17(6), 711–719.PubMedCrossRefGoogle Scholar
  6. Bougeard, G., Sesboue, R., Baert-Desurmont, S., Vasseur, S., Martin, C., Tinat, J., et al. (2008). Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. Journal of Medical Genetics, 45(8), 535–538.PubMedCrossRefGoogle Scholar
  7. Chompret, A., Brugieres, L., Ronsin, M., Gardes, M., ssarps-Freichey, F., Abel, A., et al. (2000). P53 germline mutations in childhood cancers and cancer risk for carrier individuals. British Journal of Cancer, 82(12), 1932–1937.PubMedCrossRefGoogle Scholar
  8. Clarke, A. (1994). The genetic testing of children. Working party of the clinical genetics society (UK). Journal of Medical Genetics, 31(10), 785–797.PubMedCrossRefGoogle Scholar
  9. Codori, A. M., Petersen, G. M., Boyd, P. A., Brandt, J., & Giardiello, F. M. (1996). Genetic testing for cancer in children. Short-term psychological effect. Archives of Pediatrics & Adolescent Medicine, 150(11), 1131–1138.CrossRefGoogle Scholar
  10. Codori, A. M., Zawacki, K. L., Petersen, G. M., Miglioretti, D. L., Bacon, J. A., Trimbath, J. D., et al. (2003). Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. American Journal of Medical Genetics. Part A, 116A(2), 117–128.PubMedCrossRefGoogle Scholar
  11. Duncan, R. E., Savulescu, J., Gillam, L., Williamson, R., & Delatycki, M. B. (2005). An international survey of predictive genetic testing in children for adult onset conditions. Genetics in Medicine, 7(6), 390–396.PubMedCrossRefGoogle Scholar
  12. European-Society-of-Human-genetics (2008). Genetic testing in asymptomatic minors. Accessed 4 February 2011.
  13. Evans, D. G., Lunt, P., Clancy, T., & Eeles, R. (2010). Childhood predictive genetic testing for Li-Fraumeni syndrome. Familial Cancer, 9(1), 65–69.PubMedCrossRefGoogle Scholar
  14. Frebourg, T., Abel, A., Bonaiti-Pellie, C., Brugieres, L., Berthet, P., Bressac-de, P. B., et al. (2001). Li-Fraumeni syndrome: update, new data and guidelines for clinical management. Bulletin du Cancer, 88(6), 581–587.PubMedGoogle Scholar
  15. Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., et al. (2009). Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. Journal of Clinical Oncology, 27(8), 1250–1256.PubMedCrossRefGoogle Scholar
  16. Hwang, S. J., Lozano, G., Amos, C. I., & Strong, L. C. (2003). Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. American Journal of Human Genetics, 72(4), 975–983.PubMedCrossRefGoogle Scholar
  17. Kopelman, L. M. (2007). Using the best interests standard to decide whether to test children for untreatable, late-onset genetic diseases. The Journal of Medicine and Philosophy, 32(4), 375–394.PubMedCrossRefGoogle Scholar
  18. Lammens, C.R., Aaronson, N.K., Wagner, A., Sijmons, R.H., Ausems, M.G., Vriends, A.H., et al. (2010). Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences. Journal of Clinical Oncology Google Scholar
  19. Li, F. P., & Fraumeni, J. F., Jr. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Annals of Internal Medicine, 71(4), 747–752.PubMedCrossRefGoogle Scholar
  20. Lin, M. T., Shieh, J. J., Chang, J. H., Chang, S. W., Chen, T. C., & Hsu, W. H. (2009). Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome. Pediatric Blood & Cancer, 52(4), 541–544.CrossRefGoogle Scholar
  21. Malpas, P. J. (2008). Predictive genetic testing of children for adult-onset diseases and psychological harm. Journal of Medical Ethics, 34(4), 275–278.PubMedCrossRefGoogle Scholar
  22. Marteau, T. M. (1994). The genetic testing of children. Journal of Medical Genetics, 31(10), 743.PubMedCrossRefGoogle Scholar
  23. Masciari, S., Van den Abbeele, A. D., Diller, L. R., Rastarhuyeva, I., Yap, J., Schneider, K., et al. (2008). F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA: The Journal of the American Medical Association, 299(11), 1315–1319.CrossRefGoogle Scholar
  24. Michie, S., McDonald, V., Bobrow, M., McKeown, C., & Marteau, T. (1996). Parents’ responses to predictive genetic testing in their children: report of a single case study. Journal of Medical Genetics, 33(4), 313–318.PubMedCrossRefGoogle Scholar
  25. Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: a study of emotional impact. Journal of Medical Genetics, 38(8), 519–526.PubMedCrossRefGoogle Scholar
  26. National-Comprehensive-Cancer-Network (2010). The NCCN clinical practice guidelines in OncologyT Li-Fraumeni syndrome (Version 1.2010). 2010 National Comprehensive Cancer Network, Inc. Accessed 4 Feburary 2011.
  27. Nichols, K. E., Malkin, D., Garber, J. E., Fraumeni, J. F., Jr., & Li, F. P. (2001). Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiology, Biomarkers & Prevention, 10(2), 83–87.Google Scholar
  28. Pelias, M. K. (2006). Genetic testing of children for adult-onset diseases: is testing in the child’s best interests? The Mount Sinai Journal of Medicine, 73(3), 605–608.Google Scholar
  29. Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., et al. (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Human Mutation, 28(6), 622–629.PubMedCrossRefGoogle Scholar
  30. Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893–901.PubMedCrossRefGoogle Scholar
  31. Ruijs, M. W., Verhoef, S., Rookus, M. A., Pruntel, R., van der Hout, A. H., Hogervorst, F. B., et al. (2010). TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Journal of Medical Genetics, 47(6), 421–428.PubMedCrossRefGoogle Scholar
  32. Schwartz, G. F., Hughes, K. S., Lynch, H. T., Fabian, C. J., Fentiman, I. S., Robson, M. E., et al. (2009). Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. The Breast Journal, 15(1), 4–16.PubMedCrossRefGoogle Scholar
  33. Schwarzbraun, T., Obenauf, A. C., Langmann, A., Gruber-Sedlmayr, U., Wagner, K., Speicher, M. R., et al. (2009). Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing. Journal of Medical Genetics, 46(5), 341–344.PubMedCrossRefGoogle Scholar
  34. Shepherd, M., Hattersley, A. T., & Sparkes, A. C. (2000). Predictive genetic testing in diabetes: a case study of multiple perspectives. Qualitative Health Research, 10(2), 242–259.PubMedCrossRefGoogle Scholar
  35. Shepherd, M., Ellis, I., Ahmad, A. M., Todd, P. J., Bowen-Jones, D., Mannion, G., et al. (2001). Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabetic Medicine, 18(5), 417–421.PubMedCrossRefGoogle Scholar
  36. Tarini, B. A., Tercyak, K. P., & Wilfond, B. S. (2011). Commentary: children and predictive genomic testing: disease prevention, research protection, and our future. Journal of Pediatric Psychology, 36(10), 1113–1121.PubMedCrossRefGoogle Scholar
  37. The-Children’s-Hospital-of-Philadelphia (2009). Hereditary cancer predisposition program: Li Fraumeni syndrome. 1996–2010 The Children’s Hospital of Philadelphia. Accessed 4 February 2011.
  38. Tinat, J., Bougeard, G., Baert-Desurmont, S., Vasseur, S., Martin, C., Bouvignies, E., et al. (2009). 2009 version of the Chompret criteria for Li Fraumeni syndrome. Journal of Clinical Oncology, 27(26), e108–e109.PubMedCrossRefGoogle Scholar
  39. Villani, A., Tabori, U., Schiffman, J., Shlien, A., Beyene, J., Druker, H., et al. (2011). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. The Lancet Oncology, 12(6), 559–567. doi:10.1016/s1470-2045(11)70119-x.PubMedCrossRefGoogle Scholar
  40. Went, L. (1990). Ethical issues policy statement on Huntington’s disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. Journal of Medical Genetics, 27(1), 34–38.PubMedCrossRefGoogle Scholar
  41. Wilfond, B., & Ross, L. F. (2009). From genetics to genomics: ethics, policy, and parental decision-making. Journal of Pediatric Psychology, 34(6), 639–647.PubMedCrossRefGoogle Scholar
  42. World-Medical-Association (1998). Declaration of Ottawa on child health. Accessed 11.07.2012.

Copyright information

© National Society of Genetic Counselors, Inc. 2012

Authors and Affiliations

  • Brice Fresneau
    • 1
    • 2
    • 4
  • Laurence Brugières
    • 2
    • 3
  • Olivier Caron
    • 3
  • Grégoire Moutel
    • 1
  1. 1.Laboratoire d’éthique médicale et de médecine légaleUniversité Paris DescartesParisFrance
  2. 2.Département d’Oncologie de l’enfant et de l’adolescentInstitut Gustave RoussyVillejuifFrance
  3. 3.Consultation d’OncogénétiqueInstitut Gustave RoussyVillejuifFrance
  4. 4.Laboratoire d’éthique médicale, Faculté de médecine—Centre Universitaire des Saints-PèresUniversité Paris DescartesParisFrance

Personalised recommendations